3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Ovarian Neoplasms
1
Lymphoma
1
Kidney Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
8
pembrolizumab
6
Filgrastim
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Nivolumab
4
Flow Cytometry
4
Antilymphocyte Serum
4
Alemtuzumab
4
Tacrolimus
3
Stem Cell Transplantation
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Mycophenolic Acid
3
Melphalan
3
Dexamethasone
3
Carboplatin
3
Biopsy
3
Azacitidine
3
valspodar
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Vorinostat
2
Vincristine
2
Thiotepa
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Referral and Consultation
×
Genitourinary
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts